954
T. Llamas et al.
PRACTICAL SYNTHETIC PROCEDURES
MS (FAB): m/z (%) = 360.0 (M+ + H, 100).
[a]D20 +61 (c 0.30, CHCl3).
1H NMR (300 MHz): d = 7.89–7.73 (m, 2 H), 7.67–7.59 (m, 1 H),
7.55–7.47 (m, 2 H), 7.21–7.18 (m, 1 H), 7.05–6.94 (m, 2 H), 6.92–
6.87 (m, 1 H), 4.77 (d, J = 5.4 Hz, 1 H), 4.20 (t, J = 7.9 Hz, 1 H),
3.76 (s, 3 H), 3.65–3.56 (m, 1 H), 2.76 (ddd, J = 14.0, 7.4, 4.1 Hz,
1 H), 2.45–2.17 (m, 2 H).
HRMS (EI): m/z [M + H]+ calcd for C19H22NO4S: 360.1264; found:
360.1269.
Methyl (2R,4S,5R)-5-(2-Naphthyl)-4-(phenylsulfonyl)pyrroli-
dine-2-carboxylate (7g)
White solid; yield: 71%; mp 147–148 °C; 65% ee; HPLC (Daicel
Chiralpak AS-H, i-PrOH–hexane 40:60, flow rate 0.8 mL/min, 210
nm): tR = 46.3 min (2S,4R,5S)-isomer and 50.4 min (2R,4S,5R)-iso-
mer.
13C NMR (75 MHz): d = 173.1, 162.8 (d, JF–C = 246.4 Hz), 144.0 (d,
JF-C = 7.1 Hz), 137.8, 134.0, 130.1 (d, JF-C = 8.2 Hz), 129.6, 128.5,
122.4 (d, JF-C = 2.7 Hz), 114.7 (d, JF-C = 21.4 Hz), 113.8 (d, JF-C
=
22.5 Hz), 70.2, 61.9, 59.2, 52.4, 30.7.
MS (FAB): m/z (%) = 364.1 (M+ + H, 100).
[a]D20 –46 (c 0.50, CHCl3).
1H NMR (300 MHz): d = 7.85–7.65 (m, 5 H), 7.61 (br s, 1 H), 7.54–
7.32 (m, 6 H), 4.90 (d, J = 5.5 Hz, 1 H), 4.25 (t, J = 7.9 Hz, 1 H),
3.82–3.69 (m, 4 H), 2.83–2.53 (m, 2 H), 2.43 (dt, J = 14.0, 8.9 Hz,
1 H). 13C NMR (75 MHz): d = 173.2, 138.3, 137.9, 133.8, 133.0,
132.9, 129.2, 128.5, 128.5, 127.9, 127.5, 126.2, 126.1, 126.0, 124.2,
70.0, 62.8, 59.3, 52.3, 30.9.
MS (FAB): m/z (%) = 396.2 (M+ + H, 100).
HRMS (EI): m/z [M + H]+ calcd for C22H22NO4S: 396.1272; found:
HRMS (EI): m/z [M + H]+ calcd for C18H19FNO4S: 364.1028;
found: 364.1019.
Methyl (2R,4S,5R)-5-(3-Methoxyphenyl)-4-(phenylsulfo-
nyl)pyrrolidine-2-carboxylate (7d)
Yellow oil; yield: 71%; 85% ee; HPLC (Daicel Chiralpak AS-H, i-
PrOH–hexane, 40:60, flow rate 0.8 mL/min, 210 nm): tR = 59.4 min
(2S,4R,5S)-isomer and 67.5 min (2R,4S,5R)-isomer.
[a]D20 –16 (c 0.85, CHCl3).
396.1269.
1H NMR (300 MHz): d = 7.87–7.75 (m, 2 H), 7.65–7.55 (m, 1 H),
7.54–7.41 (m, 2 H), 7.16–7.08 (m, 1 H), 6.82–6.70 (m, 3 H), 4.72
(d, J = 5.3 Hz, 1 H), 4.19 (t, J = 7.9 Hz, 1 H), 3.78–3.71 (m, 5 H),
3.69–3.59 (m, 1 H), 2.69 (ddd, J = 13.9, 7.4, 4.8 Hz, 1 H), 2.49 (br
s, 1 H), 2.45–2.27 (m, 2 H).
13C NMR (75 MHz): d = 173.3, 159.7, 142.9, 137.9, 133.8, 129.6,
129.2, 128.5, 118.8, 113.4, 112.3, 70.3, 62.6, 59.4, 55.1, 52.3, 30.9.
Methyl (2R,4S,5R)-5-Cyclohexyl-4-(phenylsulfonyl)pyrroli-
dine-2-carboxylate (7h)
Colorless oil; yield: 50%; 69% ee; HPLC (Daicel Chiralpak AS-H,
i-PrOH–hexane, 40:60, flow rate 0.8 mL/min, 210 nm): tR = 22.7
min (2R,4S,5R)-isomer and 25.3 min (2S,4R,5S)-isomer.
[a]D20 +3 (c 0.31, CHCl3).
1H NMR (300 MHz): d = 7.95–7.85 (m, 2 H), 7.72–7.54 (m, 3 H),
3.99 (dd, J = 9.6, 7.1 Hz, 1 H), 3.71 (s, 3 H), 3.57–3.39 (m, 2 H),
2.50 (ddd, J = 14.1, 6.9, 2.5 Hz, 1 H), 2.20–1.96 (m, 2 H), 1.77–1.54
(m, 5 H), 1.32–0.81 (m, 6 H).
MS (FAB): m/z (%) = 376.0 (M+ + H, 100).
HRMS (EI): m/z [M + H]+ calcd for C19H22NO5S: 376.1232; found:
376.1219.
13C NMR (75 MHz): d = 173.4, 138.2, 133.9, 129.4, 128.7, 66.0,
Methyl (2R,4S,5R)-4-(Phenylsulfonyl)-5-(3-tolyl)pyrrolidine-2-
carboxylate (7e)
White solid; yield: 74%; 79% ee; mp 93–94 °C.
63.9, 59.3, 52.2, 42.1, 31.7, 30.3, 28.2, 26.2, 26.1, 25.9.
MS (FAB): m/z (%) = 352.0 (M+ + H, 100).
[a]D20 –19 (c 0.27, CHCl3).
HRMS (EI): m/z [M + H]+ calcd for C18H26NO4S: 352.1584; found:
352.1583.
1H NMR (300 MHz): d = 7.87–7.75 (m, 2 H), 7.63–7.54 (m, 1 H),
7.51–7.42 (m, 2 H), 7.15–7.05 (m, 1 H), 7.04–6.95 (m, 2 H), 6.94–
6.87 (m, 1 H), 4.65 (d, J = 5.8 Hz, 1 H), 4.17 (t, J = 7.8 Hz, 1 H),
3.76 (s, 3 H), 3.71–3.61 (m, 1 H), 2.80–2.64 (m, 1 H), 2.62–2.30 (m,
2 H), 2.24 (s, 3 H).
13C NMR (75 MHz): d = 173.2, 140.6, 138.1, 138.0, 133.8, 129.1,
128.6, 128.5, 127.5, 123.8, 70.0, 62.9, 59.3, 52.3, 31.1, 21.3.
Methyl (2R,4S,5R)-2-Methyl-5-phenyl-4-(phenylsulfonyl)pyr-
rolidine-2-carboxylate (7i)
White solid; yield: 45%; mp 82–83 °C; 80% ee; HPLC (Daicel
Chiralpak AS-H, i-PrOH–hexane 40:60, flow rate 0.8 mL/min, 210
nm): tR = 16.6 min (2S,4R,5S)-isomer and 19.9 min (2R,4S,5R)-iso-
mer.
MS (FAB): m/z (%) = 360.0 (M+ + H, 100).
HRMS (EI): m/z [M + H]+ calcd for C19H22NO4S: 360.1263; found:
[a]D20 –5 (c 0.30, CHCl3).
1H NMR (300 MHz): d = 7.74–7.65 (m, 2 H), 7.53–7.44 (m, 1 H),
7.39–7.32 (m, 2 H), 7.15 (br s, 5 H), 4.66 (d, J = 8.3 Hz, 1 H), 3.87
(c, J = 8.6 Hz, 1 H), 3.71 (s, 3 H), 2.79 (dd, J = 13.7, 8.5 Hz, 1 H),
2.61 (br s, 1 H), 2.36 (dd, J = 13.6, 9.6 Hz, 1 H), 1.56 (s, 3 H).
13C NMR (75 MHz): d = 176.2, 139.8, 138.4, 133.6, 129.0, 128.5,
128.2, 127.8, 127.1, 69.8, 65.0, 63.3, 52.6, 38.5, 26.0.
360.1269.
Methyl (2R,4S,5R)-4-(Phenylsulfonyl)-5-(2-tolyl)pyrrolidine-2-
carboxylate (7f)
White solid; yield: 92%; mp 112–113 °C; 41% ee; HPLC (Daicel
Chiralpak AS-H, i-PrOH–hexane, 40:60, flow rate 0.8 mL/min, 210
nm): tR = 26.8 min (2S,4R,5S)-isomer and 30.1 min (2R,4S,5R)-iso-
mer.
MS (EI): m/z (%) = 360.1 (M+ + H, 100).
HRMS (EI): Calcd for C19H22NO4S: 360.1268; found: 360.1269.
[a]D20 –16 (c 0.50, CHCl3).
Methyl (2R,4S,5R)-1-Methyl-5-phenyl-4-(phenylsulfonyl)pyr-
rolidine-2-carboxylate (8); Typical Procedure
1H NMR (300 MHz): d = 7.84–7.74 (m, 2 H), 7.63–7.53 (m, 1 H),
7.51–7.41 (m, 2 H), 7.15–7.06 (m, 1 H), 7.05–6.96 (m, 2 H), 6.92
(br s, 1 H), 4.65 (d, J = 5.9 Hz, 1 H), 4.17 (t, J = 7.9 Hz, 1 H), 3.77
(s, 3 H), 3.72–3.70 (m, 1 H), 2.72 (ddd, J = 14.0, 7.1, 4.4 Hz, 1 H),
2.60–2.30 (m, 2 H), 2.24 (s, 3 H).
13C NMR (75 MHz): d = 173.2, 140.6, 138.1, 138.0, 133.8, 129.1,
129.2, 128.6, 128.5, 127.5, 123.8, 70.0, 62.9, 59.3, 52.3, 31.1, 21.3.
To a soln of 3a (500 mg, 1.4 mmol) and K2CO3 (796 mg, 5.8 mmol)
in DMF (14 mL) at r.t. was added MeI (130 mL, 2.1 mmol). The
mixture was stirred for 4 h and then Et2O (20 mL) was added. The
mixture was washed with H2O (3 × 10 mL) and the aqueous phase
was extracted with Et2O (20 mL). The combined organic phases
were dried (MgSO4) and concentrated. The residue was purified by
flash chromatography (n-hexane–EtOAc, 2:1) to afford 8 as a white
Synthesis 2007, No. 6, 950–956 © Thieme Stuttgart · New York